Overview
- 76 inspections across 70 sites are on record.
- 249 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-04-25.
At a glance
Inspections
76
Sites
70
Observations
249
Career since
Sep 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Positive Promotions Inc. | 25 Apr 2022 | Human Drugs | View 483 → |
| DuPont Nutrition USA, Inc | 15 Dec 2021 | Human Drugs | On file |
| Frontage Laboratories, Inc. | 15 Oct 2021 | Human Drugs | View 483 → |
| Genus Lifesciences Inc. | 23 Jul 2021 | Human Drugs | |
| Douglas Pharma US | 15 Jun 2021 | Human Drugs | View 483 → |
Sites inspected
Positive Promotions Inc.Hauppauge, United States1 insp.
DuPont Nutrition USA, IncNewark, United States1 insp.
Frontage Laboratories, Inc.Exton, United States1 insp.
Genus Lifesciences Inc.Allentown, United States1 insp.
Douglas Pharma USWarminster, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Matthew R Noonan14 shared
Derek S Dealy7 shared
Christina K Theodorou6 shared
David A Oluwo6 shared
Nikisha M Bolden3 shared
Kristina L Conroy2 shared
Rachael O Oyewole2 shared
Brian D Young2 shared
Gayle S Lawson2 shared
Edwin L Hobbs2 shared
Full investigator report
Get the verbatim findings behind Craig D Zagata's 249 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site